Woman and Man
- | Country :
- Italy
- Germany
- France
- The 8 others...
- | organs : -
- | Specialty : -
Extract
This 6-month open label study will evaluate the long term safety of bosentan (via oxygen saturation) and efficacy (exercise capacity) in patients who have completed the BREATHE-5 study (PAH related to Eisenmenger physiology). Treatment duration is 6 months.
Inclusion criteria
- pulmonary arterial hypertension